Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study

BackgroundSurgery is the main curative therapeutic strategy for patients with initial primary lung cancer (IPLC). Most international guidelines recommend regular follow-ups after discharge to monitor patients for tumor recurrence and metastasis. As the overall survival (OS) in patients with lung can...

Full description

Bibliographic Details
Main Authors: You Mo, Minxin Chen, Meng Wu, Dawei Chen, Jinming Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.918137/full
_version_ 1817983485278683136
author You Mo
You Mo
Minxin Chen
Minxin Chen
Meng Wu
Dawei Chen
Jinming Yu
Jinming Yu
Jinming Yu
author_facet You Mo
You Mo
Minxin Chen
Minxin Chen
Meng Wu
Dawei Chen
Jinming Yu
Jinming Yu
Jinming Yu
author_sort You Mo
collection DOAJ
description BackgroundSurgery is the main curative therapeutic strategy for patients with initial primary lung cancer (IPLC). Most international guidelines recommend regular follow-ups after discharge to monitor patients for tumor recurrence and metastasis. As the overall survival (OS) in patients with lung cancer improves, their risk of secondary primary lung cancer (SPLC) increases. Previous studies on such patients lack separate assessment of different survival outcomes and evaluation of high-risk factors for SPLC. Therefore, we aimed to determine the correlation between high-risk factors and causes of death in patients with SPLC, based on the Surveillance, Epidemiology, and End Results (SEER) database.MethodsWe screened the SEER database for patients with IPLC and SPLC from 2004 to 2015 and included only patients who underwent surgery since the IPLC and in whom the cancer was pathologically verified of an International Classification of Diseases grade of 0-3 and to be non-small-cell lung cancer. The standardized incidence ratio (SIR) was calculated between variables and SPLC. Multivariable Cox proportional-hazards regression analyses were conducted to calculate the correlation of different variables with overall survival (OS) and cancer-specific survival (CSS). A competing-risk model was conducted for SPLC. The effect of baseline bias on survival outcomes by performing propensity score matching analysis in a 1: 6 ratio (SPLC: IPLC).ResultsFor patients aged 0-49 years, the overall SIR was higher in older patients, reaching a maximum of 27.74 in those aged 40-49 years, and at 11.63 in patients aged 50-59 years. The overall SIR was higher for patients who were more recently diagnosed with IPLC and increased with time after diagnosis. Male sex, SPLC (hazard ratio, 1.6173; 95% confidence interval, 1.5505-1.6869; P < 0.001), cancer grade III or IV, lower lobe of the lung, advanced stage and postoperative radiotherapy (PORT) were independently detrimental to OS. In terms of CSS, PORT was a high-risk factor.ConclusionsPostoperative radiotherapy is a risk factor for second primary lung cancer and detrimental to overall and cancer-specific survival in patients who had initial primary lung cancer. These data support the need for life-long follow-up of patients who undergo treatment for IPLC to screen for SPLC.
first_indexed 2024-04-13T23:33:45Z
format Article
id doaj.art-d1221680deae49b2b19c65748f1f18e6
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-13T23:33:45Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-d1221680deae49b2b19c65748f1f18e62022-12-22T02:24:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-10-011210.3389/fonc.2022.918137918137Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based studyYou Mo0You Mo1Minxin Chen2Minxin Chen3Meng Wu4Dawei Chen5Jinming Yu6Jinming Yu7Jinming Yu8Department of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Cardiovascular Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, ChinaDepartment of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaBackgroundSurgery is the main curative therapeutic strategy for patients with initial primary lung cancer (IPLC). Most international guidelines recommend regular follow-ups after discharge to monitor patients for tumor recurrence and metastasis. As the overall survival (OS) in patients with lung cancer improves, their risk of secondary primary lung cancer (SPLC) increases. Previous studies on such patients lack separate assessment of different survival outcomes and evaluation of high-risk factors for SPLC. Therefore, we aimed to determine the correlation between high-risk factors and causes of death in patients with SPLC, based on the Surveillance, Epidemiology, and End Results (SEER) database.MethodsWe screened the SEER database for patients with IPLC and SPLC from 2004 to 2015 and included only patients who underwent surgery since the IPLC and in whom the cancer was pathologically verified of an International Classification of Diseases grade of 0-3 and to be non-small-cell lung cancer. The standardized incidence ratio (SIR) was calculated between variables and SPLC. Multivariable Cox proportional-hazards regression analyses were conducted to calculate the correlation of different variables with overall survival (OS) and cancer-specific survival (CSS). A competing-risk model was conducted for SPLC. The effect of baseline bias on survival outcomes by performing propensity score matching analysis in a 1: 6 ratio (SPLC: IPLC).ResultsFor patients aged 0-49 years, the overall SIR was higher in older patients, reaching a maximum of 27.74 in those aged 40-49 years, and at 11.63 in patients aged 50-59 years. The overall SIR was higher for patients who were more recently diagnosed with IPLC and increased with time after diagnosis. Male sex, SPLC (hazard ratio, 1.6173; 95% confidence interval, 1.5505-1.6869; P < 0.001), cancer grade III or IV, lower lobe of the lung, advanced stage and postoperative radiotherapy (PORT) were independently detrimental to OS. In terms of CSS, PORT was a high-risk factor.ConclusionsPostoperative radiotherapy is a risk factor for second primary lung cancer and detrimental to overall and cancer-specific survival in patients who had initial primary lung cancer. These data support the need for life-long follow-up of patients who undergo treatment for IPLC to screen for SPLC.https://www.frontiersin.org/articles/10.3389/fonc.2022.918137/fullinitial primary lung cancersecondary primary lung cancerstandardized incidence ratio (SIR)postoperative radiotherapyoverall survival (OS)cancer-specific survival (CSS)
spellingShingle You Mo
You Mo
Minxin Chen
Minxin Chen
Meng Wu
Dawei Chen
Jinming Yu
Jinming Yu
Jinming Yu
Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
Frontiers in Oncology
initial primary lung cancer
secondary primary lung cancer
standardized incidence ratio (SIR)
postoperative radiotherapy
overall survival (OS)
cancer-specific survival (CSS)
title Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
title_full Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
title_fullStr Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
title_full_unstemmed Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
title_short Postoperative radiotherapy might be a risk factor for second primary lung cancer: A population-based study
title_sort postoperative radiotherapy might be a risk factor for second primary lung cancer a population based study
topic initial primary lung cancer
secondary primary lung cancer
standardized incidence ratio (SIR)
postoperative radiotherapy
overall survival (OS)
cancer-specific survival (CSS)
url https://www.frontiersin.org/articles/10.3389/fonc.2022.918137/full
work_keys_str_mv AT youmo postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT youmo postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT minxinchen postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT minxinchen postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT mengwu postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT daweichen postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT jinmingyu postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT jinmingyu postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy
AT jinmingyu postoperativeradiotherapymightbeariskfactorforsecondprimarylungcancerapopulationbasedstudy